Healios K.K. (OTCMKTS:HLOSF) Short Interest Up 159.5% in February

Healios K.K. (OTCMKTS:HLOSF) was the target of a large growth in short interest in the month of February. As of February 15th, there was short interest totalling 34,000 shares, a growth of 159.5% from the January 31st total of 13,100 shares. Based on an average daily volume of 100 shares, the short-interest ratio is currently 340.0 days.

Healios K.K. Price Performance

Shares of HLOSF stock remained flat at $2.42 during trading hours on Friday. Healios K.K. has a one year low of $0.93 and a one year high of $2.42. The business’s 50-day moving average is $1.11 and its two-hundred day moving average is $1.35.

Healios K.K. Company Profile

Healios K.K. engages in the research and development, manufacture, and sale of cell therapy and regenerative medicine products in Japan, Europe, and the United States. The company offers HLCM051 for treatment of ischemic stroke and acute respiratory distress syndrome; HLCN061 for treating solid tumors; HLCR011 for the treatment of retinal pigment epithelium tear and age-related macular degeneration; and HLCL041 for liver disease.